Investigational Site Number : 2880001

Navrongo 114

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Respiratory Syncytial Virus Infections

Studies at this site

• Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older — Stopped early
• Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers — Completed